Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
In addition to workforce reductions, 23andMe has also decided to discontinue its therapeutic ... The situation worsened in ...
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
23andMe's CEO called the decision to lay off 200 employees ... The suffering company faced another blow in September when its board of directors resigned. The board’s seven members quit after ...
In September, independent directors of the Board of 23andMe sent a letter to Anne Wojcicki, Chief Executive Officer, Co ...
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
Shares were hovering below $1 until 23andMe announced a 1-for-20 reverse stock split in October. In September, all seven of ...
Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing ...